In Silico Prediction of Blood-Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter

The cross-sectional area, AD, of a compound oriented in an amphiphilic gradient such as the air-water or lipid-water interface has previously been shown to be crucial for membrane partitioning and permeation, respectively. Here, we developed an algorithm that determines the molecular axis of amphiphilicity and the cross-sectional area, ADcalc, perpendicular to this axis. Starting from the conformational ensemble of each molecule, the three-dimensional conformation selected as the membrane-binding conformation was the one with the smallest cross-sectional area, ADcalcM, and the strongest amphiphilicity. The calculated, ADcalcM, and the measured, AD, cross-sectional areas correlated linearly (n=55, slope, m=1.04, determination coefficient, r2=0.95). The calculated cross-sectional areas, ADcalcM, were then used together with the calculated octanol-water distribution coefficients, log D7.4, of the 55 compounds (with a known ability to permeate the blood-brain barrier) to establish a calibration diagram for the prediction of blood-brain barrier permeation. It yielded a limiting cross-sectional area (ADcalcM=70 A2) and an optimal range of octanol-water distribution coefficients (-1.4<or=log D7.4<7.0). The calibration diagram was validated with an independent set of 43 compounds with the known ability to permeate the blood-brain barrier, yielding a prediction accuracy of 86%. The incorrectly predicted compounds exhibited log D7.4 values comprised between -0.6 and -1.4, suggesting that the limitation for log D7.4 is less rigorous than the limitation for AD. An accuracy of 83% has been obtained for a second validation set of 42 compounds which were previously shown to be difficult to predict. The calculated parameters, ADcalcM and log D7.4, thus allow for a fast and accurate prediction of blood-brain barrier permeation. Analogous calibration diagrams can be established for other membrane barriers.

[1]  H. Waterbeemd Physicochemical Approaches to Drug Absorption , 2008 .

[2]  Grégori Gerebtzoff,et al.  Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding , 2006, Expert opinion on drug metabolism & toxicology.

[3]  Yvan Vander Heyden,et al.  Classification Tree Models for the Prediction of Blood-Brain Barrier Passage of Drugs , 2006, J. Chem. Inf. Model..

[4]  Ramamurthi Narayanan,et al.  In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.

[5]  A. Seelig,et al.  Inhibitors of multidrug efflux transporters: their membrane and protein interactions. , 2005, Mini reviews in medicinal chemistry.

[6]  Gerhard F. Ecker,et al.  In silico prediction models for blood-brain barrier permeation. , 2004, Current medicinal chemistry.

[7]  Grégori Gerebtzoff,et al.  Halogenation of Drugs Enhances Membrane Binding and Permeation , 2004, Chembiochem : a European journal of chemical biology.

[8]  P. Kinnunen,et al.  Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. , 2004, Journal of medicinal chemistry.

[9]  A. Crowe,et al.  pH Dependent Uptake of Loperamide Across the Gastrointestinal Tract: An In Vitro Study , 2004, Drug development and industrial pharmacy.

[10]  D. E. Clark In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.

[11]  U. Norinder,et al.  Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.

[12]  Kin Yip Tam,et al.  Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study , 2001 .

[13]  B. Faller,et al.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.

[14]  M. Kansy,et al.  CAFCA: a Novel Tool for the Calculation of Amphiphilic Properties of Charged Drug Molecules , 2000, CHIMIA.

[15]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[16]  L. Lai,et al.  Calculating partition coefficient by atom-additive method , 2000 .

[17]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[18]  B. Müller,et al.  Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.

[19]  L. Fenart,et al.  In vitro model for evaluating drug transport across the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[20]  T. de Boer,et al.  Modelling of conditions for the enantiomeric separation of beta2-adrenergic sympathicomimetics by capillary electrophoresis using cyclodextrins as chiral selectors in a polyethylene glycol gel. , 1999, Journal of pharmaceutical and biomedical analysis.

[21]  팔러모필립 A method of preventing abuse of opioid dosage forms , 1998 .

[22]  A. Seelig,et al.  Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.

[23]  K Gubernator,et al.  Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.

[24]  Renzo Balducci,et al.  Efficient exact solution of the ring perception problem , 1994, J. Chem. Inf. Comput. Sci..

[25]  S. McLaughlin,et al.  Effect of monolayer surface pressure on the activities of phosphoinositide-specific phospholipase C-beta 1, -gamma 1, and -delta 1. , 1994, Biochemistry.

[26]  A. Seelig,et al.  A method to determine the ability of drugs to diffuse through the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Kontturi,et al.  Electrochemical determination of partition coefficients of drugs. , 1992, Journal of pharmaceutical sciences.

[28]  L. Austin,et al.  Clomipramine: an antiobsessional tricyclic antidepressant. , 1990, Clinical pharmacy.

[29]  L. Turnberg,et al.  Water movement through lipid bilayers, pores, and plasma membranes , 1988 .

[30]  A. Seelig,et al.  Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. , 1987, Biochimica et biophysica acta.

[31]  P. Jurs,et al.  Molecular shape and the prediction of high-performance liquid chromatographic retention indexes of polycyclic aromatic hydrocarbons. , 1987, Analytical chemistry.

[32]  R. Barlow,et al.  THE EFFECTS OF pH ON THE AFFINITY OF PIRENZEPINE FOR MUSCARINIC RECEPTORS IN THE GUINEA‐PIG ILEUM AND RAT FUNDUS STRIP , 1982, British journal of pharmacology.

[33]  J. Seelig,et al.  Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.

[34]  F M Richards,et al.  Areas, volumes, packing and protein structure. , 1977, Annual review of biophysics and bioengineering.

[35]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[36]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[37]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[38]  W. Meylan,et al.  Atom/fragment contribution method for estimating octanol-water partition coefficients. , 1995, Journal of pharmaceutical sciences.

[39]  M. Nakashima,et al.  Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. , 1994, Arzneimittel-Forschung.

[40]  D E Green,et al.  Membrane structure. , 1971, Science.